Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Long-Term Debt Repayments (2018 - 2021)

Historic Long-Term Debt Repayments for Creative Medical Technology Holdings (CELZ) over the last 3 years, with Q4 2021 value amounting to $4.5 million.

  • Creative Medical Technology Holdings' Long-Term Debt Repayments changed N/A to $4.5 million in Q4 2021 from the same period last year, while for Dec 2022 it was $5.1 million, marking a year-over-year decrease of 135.31%. This contributed to the annual value of $5.3 million for FY2021, which is N/A changed from last year.
  • As of Q4 2021, Creative Medical Technology Holdings' Long-Term Debt Repayments stood at $4.5 million.
  • Over the past 5 years, Creative Medical Technology Holdings' Long-Term Debt Repayments peaked at $4.5 million during Q4 2021, and registered a low of $800.0 during Q1 2018.
  • Moreover, its 3-year median value for Long-Term Debt Repayments was $178650.0 (2018), whereas its average is $715121.8.
  • Over the last 5 years, Creative Medical Technology Holdings' Long-Term Debt Repayments had its largest YoY gain of 2093750.0% in 2019, and its largest YoY loss of 8802.24% in 2019.
  • Over the past 3 years, Creative Medical Technology Holdings' Long-Term Debt Repayments (Quarter) stood at $215494.0 in 2018, then tumbled by 67.84% to $69300.0 in 2019, then soared by 6459.55% to $4.5 million in 2021.
  • Its Long-Term Debt Repayments was $4.5 million in Q4 2021, compared to $506498.0 in Q3 2021 and $69300.0 in Q4 2019.